CHRISTINE HOOPER: Open Payments
NPI 1023037785 · LANGHORNE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,653 in 64 payments from 15 companies in 2025. Trend: 2023 $833 · 2024 $1,049 · 2025 $2,653
Food & beverage: $2,653
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $442 |
| AKEBIA THERAPEUTICS INC | 8 | $375 |
| Vantive US Healthcare LLC | 4 | $314 |
| Fresenius USA Marketing, Inc. | 11 | $280 |
| Novo Nordisk Inc | 3 | $234 |
| Novartis Pharmaceuticals Corporation | 10 | $197 |
| Ardelyx, Inc. | 5 | $152 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $140 |
| Calliditas Therapeutics US Inc. | 1 | $122 |
| Gilead Sciences, Inc. | 1 | $117 |
Products named: Vafseo, Renal - Chronic, VELPHORO, BREZTRI, Ozempic, XPHOZAH 30 MG, TARPEYO, FASENRA.
Industry payments across PA — which companies pay providers there.
